Advertisement

Clinical Indications for Continuous Glucose Monitoring

Chapter

Abstract

This chapter introduces the indications of continuous glucose monitoring (CGM) technology in clinical application. We will explain and compare the advantages, application scope, and indications of retrospective and real-time CGM systems. We will also describe how retrospective CGM can be used as a valuable tool to evaluate the results of clinical studies when appropriate. At the end, we will discuss the population that is suitable for real-time CGM.

Keywords

Retrospective continuous glucose monitoring Real-time continuous glucose monitoring Indications 

References

  1. 1.
    Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2009). Zhonghua Yi Xue Za Zhi. 2009;89:3388–92.  https://doi.org/10.3760/cma.j.issn.0376-2491.2009.48.002.CrossRefGoogle Scholar
  2. 2.
    Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2012). Chin J Diabetes Mellitus. 2012;4:582–90.  https://doi.org/10.3760/cma.j.issn.1674-5809.2012.10.003.CrossRefGoogle Scholar
  3. 3.
    Chinese Diabetes Society. Clinical application guide of blood glucose monitoring in China (Edition 2015). Chin J Diabetes Mellitus. 2015;7:603–13.  https://doi.org/10.3760/cma.j.issn.1764-5809.2015.10.004.CrossRefGoogle Scholar
  4. 4.
    Tao M, Zhou J, Zhu J, Lu W, Jia W. Continuous glucose monitoring reveals abnormal features of postprandial glycemic excursions in women with polycystic ovarian syndrome. Postgrad Med. 2011;123:185–90.  https://doi.org/10.3810/pgm.2011.03.2277.CrossRefPubMedGoogle Scholar
  5. 5.
    Zhou J, Mo Y, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Jia W. Alanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulation. PLoS One. 2013;8:e56072.  https://doi.org/10.1371/journal.pone.0056072.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H, Endocrine Society. Continuous glucose monitoring: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:2968–79.  https://doi.org/10.1210/jc.2010-2756.CrossRefPubMedGoogle Scholar
  7. 7.
    Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:3922–37.CrossRefPubMedGoogle Scholar
  8. 8.
    Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W, Consensus Conference Writing Committee. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22:1008–21.  https://doi.org/10.4158/EP161392.CS.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers 2018

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes InstituteShanghai Jiao Tong University, Affiliated Sixth People’s HospitalShanghaiChina

Personalised recommendations